Inventor
MORGENTHALER NILS
DE12 patents
⚠️ This page may combine multiple inventors who share the name “MORGENTHALER NILS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BERGMANN ANDREAS
6 patentsUS8465941B2Jun 18, 2013
Procalcitonin-based diagnosis of infections or inflammatory diseases of the respiratory tract in a patient with heart failure
BERGMANN ANDREAS14 citations83
US8252544B2Aug 28, 2012
Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients
BERGMANN ANDREAS13 citations83
US8524463B2Sep 3, 2013
Diagnosis and risk classification of acute coronary syndrome by means of CT-proET-1 in combination with NT-proBNP
BERGMANN ANDREAS10 citations82
US8647830B2Feb 11, 2014
Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac disease
BERGMANN ANDREAS5 citations72
US8501485B2Aug 6, 2013
Risk stratification for acute coronary syndrome by determining copeptin
BERGMANN ANDREAS4 citations72
US8158368B2Apr 17, 2012
Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II
BERGMANN ANDREAS1 citations51
BRAHMS GMBH
4 patentsUS10718783B2Jul 21, 2020
Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II
BRAHMS GMBH0 citations51
US10067063B2Sep 4, 2018
Prognosis and risk assessment in stroke patients by determining the level of marker peptides
BRAHMS GMBH1 citations51
US10254289B2Apr 9, 2019
In vitro method for early or differential diagnosis or prognosis of myocardial infarction in a patient
BRAHMS GMBH0 citations50
US9261517B2Feb 16, 2016
Diagnosis of acute coronary syndrome, myocardial infarction, or angina pectoris by means of neurophysin II
BRAHMS GMBH0 citations50